logo-loader

KaloBios Pharmaceuticals

Receive alerts
Market:
NASDAQ
Market Cap:
£0.00
Price
0.00 0
Change
0%
52 weeks high
0
52 weeks low
0

In brief

KaloBios Pharmaceuticals is a biopharmaceutical company. The Company is focused on the development of monoclonal antibody therapeutics for diseases that represent a burden to society and to patients and their families.